B7-33 peptide, or B-type Natriuretic Peptide (BNP) 7-33, is a truncated form of the B-type natriuretic peptide. This peptide has been a subject of significant interest in the field of cardiovascular research due to its cardio-protective properties. One of the most notable benefits of B7-33 is its ability to reduce myocardial infarct size. In addition to its cardioprotective effects, B7-33 also exhibits anti-fibrotic properties. It has been demonstrated to inhibit cardiac fibrosis, thereby improving cardiac function and potentially delaying the progression of heart failure.
Showing all 3 results
SALE
20% OFF
[1] https://pubmed.ncbi.nlm.nih.gov/32295457/
[2] https://pubmed.ncbi.nlm.nih.gov/30155023/
[3] https://www.mdpi.com/ 1422-0067/24/16/12670
[4] https://www.sciencedirect.com/science/ article/pii/S0753332223001580
[5] https://www.ncbi.nlm.nih.gov/pmc/ articles/PMC8213244/
[6] https://pubmed.ncbi.nlm.nih.gov/33555858/
[7] https://www.mdpi.com/ 2218-273X/13/8/1179
DISCLAIMER: We do not supply peptides to any individual under the age of 21. You must be a licensed and qualified healthcare practitioner. Our team of dedicated professionals are committed to providing an extensive range of products used ONLY in the process of laboratory research by responsible trained and professional individuals. All products listed on this website (https://indonesia.direct-peptides.com) and provided through Direct Peptides are intended for laboratory research purposes only. The products listed on this website are NOT for human or animal consumption or ingestion of any kind.
401 N. Mills Ave, Ste B, Orlando, FL 32803, United States